'I can see no logic to NICE's decision that patients already prescribed beta interferon
can have the drug but new patients cannot - either the drug is effective or it is not.'
Multiple sclerosis sufferer Jason Lee Powell, 33, from Whitland, was refused beta interferon
because of the cost implications.
is not suitable for all MS sufferers but can reduce the frequency of relapses in the intermittent form of the condition.
is currently under review by the Government's medicine rationing body, the National Institute for Clinical Excellence (NICE), set up to end the postcode lottery of treatment in the NHS.
But the decision will now be delayed because health chiefs in England - who had previously labelled beta interferon
too expensive - are on the verge of a U-turn over its use.
Now the National Institute for Clinical Excellence has ruled against making beta interferon
available on the NHS, in a move which will come as a massive blow to sufferers.
There is already "post-code prescribing", the denial of expensive drugs like Beta Interferon
to MS sufferers and patients who are written off as DNR (Do Not Resuscitate).
"We're proud of our contributions to the Copaxone clinical trial and to the early research on interferons that contributed to beta interferon
A GOVERNMENT U-turn on the anti-MS drug beta interferon
may have come too late for father-of-three Ian Wilding.
THE recommendation by the National Institute for Clinical Excellence (NICE) that the NHS stop prescribing Beta Interferon
to multiple sclerosis victims is outrageous.
Guest speaker Nigel Ellis, director of branch and regional support for the society, spoke about the problems surrounding the availability of the drug beta interferon
which can help some people with MS.
Denise Newton describes beta interferon
as the 'gift of time' which has halted the progress of the devastating illness.